GOCO vs HERZ
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
GOCO exhibits severe financial distress, anchored by a critical Piotroski F-Score of 1/9, indicating a near-total failure of fundamental health metrics. The company is experiencing a catastrophic collapse in top-line performance with YoY revenue growth plummeting -96.80% and an operating margin of -252.92%. While the stock trades at a deep discount to book value (P/B 0.45) and sales (P/S 0.08), these appear to be value traps given the trajectory of the business. Despite a bullish analyst target of $4.70, the deterministic data suggests a company in a death spiral with a -99.4% five-year price return.
HERZ exhibits severe financial instability, highlighted by a weak Piotroski F-Score of 3/9 and a critical liquidity crisis with a current ratio of 0.05. While the stock trades at a discount to book value (P/B 0.75), it is significantly overpriced relative to its Graham Number ($9.81) and Intrinsic Value ($1.40). The most alarming factor is the unsustainable dividend yield of 57.69% with a payout ratio exceeding 1100%, characterizing this as a classic dividend trap. Despite strong revenue growth, the collapse in earnings (-73% YoY) and negative profit margins indicate a failing operational model.
Compare Another Pair
Related Comparisons
GOCO vs HERZ: Head-to-Head Comparison
This page compares GoHealth, Inc. (GOCO) and Herzfeld Credit Income Fund, Inc. (HERZ) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.